Select the publication year
Select an author  
  • A link between two tumorigenic proteins, CD44 and p21(WAF1): CD44 increases phorbol ester-induced expression of p21(WAF1) by stabilizing its mRNA and extending protein half-life.
    Lindner C, Urbánek P, Pavelka B, Hartmann M, Herrlich P
    FEBS Lett 2013, 587(16), 2698-704
  • BSTA: a targeted approach combines bulked segregant analysis with next- generation sequencing and de novo transcriptome assembly for SNP discovery in sunflower.
    Livaja M, Wang Y, Wieckhorst S, Haseneyer G, Seidel M, Hahn V, Knapp SJ, Taudien S, Schön CC, Bauer E
    BMC Genomics 2013, 14, 628
  • Genomics-based high-resolution mapping of the BaMMV/BaYMV resistance gene rym11 in barley (Hordeum vulgare L.).
    Lüpken T, Stein N, Perovic D, Habekuß A, Krämer I, Hähnel U, Steuernagel B, Scholz U, Zhou R, Ariyadasa R, Taudien S, Platzer M, Martis M, Mayer K, Friedt W, Ordon F
    Theor Appl Genet 2013, 126(5), 1201-12
  • An investigation of the effects of the antioxidants, ebselen or N-acetyl cysteine on human peripheral blood mononuclear cells and T cells.
    Marthandan S, Hyland P, Pawelec G, Barnett Y
    Immun Ageing 2013, 10(1), 7
  • Analysis of mouse mutants deficient in the thyroid hormone transporters Mct8 and Oatp1c1
    Mayerl S
    Dissertation 2013, Jena, Germany
  • RNAi screening uncovers Dhx9 as a modifier of ABT-737 resistance in an Eμ-myc/Bcl-2 mouse model.
    Mills JR, Malina A, Lee T, Di Paola D, Larsson O, Miething C, Grosse F, Tang H, Zannis-Hadjopoulos M, Lowe SW, Pelletier J
    Blood 2013, 121(17), 3402-12
  • Poly(ADP-ribose) binding to Chk1 at stalled replication forks is required for S-phase checkpoint activation.
    Min W, Bruhn C, Grigaravicius P, Zhou ZW, Li F, Krüger A, Siddeek B, Greulich KO, Popp O, Meisezahl C, Calkhoven CF, Bürkle A, Xu X, Wang ZQ
    Nat Commun 2013, 4, 2993
  • Structural insights into the interaction of a high-risk human papillomavirus wild-type oncoprotein E6
    Mischo A
    Dissertation 2013, Jena, Germany
  • Structural insights into a wildtype domain of the oncoprotein E6 and its interaction with a PDZ domain.
    Mischo A, Ohlenschläger O, Hortschansky P, Ramachandran R, Görlach M
    PLoS One 2013, 8(4), e62584
  • NMR assignment of a PDZ domain in complex with a HPV51 E6 derived N-terminally pyroglutamic acid modified peptide.
    Mischo A, Ohlenschläger O, Ramachandran R, Görlach M
    Biomol NMR Assign 2013, 7(1), 47-9